EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

Multidisciplinary Delphi Consensus on the Clinical Use of Intranasal Carboxymethyl-β-Glucan-Resveratrol: Evidence-Based Recommendations for Upper Airway Diseases

Giorgio Ciprandi iD, Germano Bettoncelli, Ignazio La Mantia iD, Paola Mastromarino, Michele Miraglia Del Giudice iD, Giovanni Arturo Rossi, Oliviero Rossi, Matteo Gelardi iD, Attilio Varricchio

Journal of Clinical Medicine · 17.04.2026 · 15 (8) · 3087

DOI: 10.3390/jcm15083087 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.04.2026. Verfasst von Giorgio Ciprandi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Intranasal carboxymethyl-β-glucan (CMBG)-resveratrol represents an innovative therapeutic approach for upper airway diseases, combining antimicrobial, anti-inflammatory, antioxidant, immunomodulatory, and antiallergic properties. Despite growing preclinical and clinical evidence, consensus on its clinical applications remains poorly defined. To establish evidence-based recommendations for the clinical use of intranasal CMBG-resveratrol through a multidisciplinary Delphi Consensus process.

Methods

A two-round Delphi Consensus was conducted. In the first round, an expert board prepared, reviewed, and validated 22 statements based on current scientific evidence from preclinical and clinical studies. In the second round, 38 multidisciplinary experts evaluated each statement using a 5-point Likert scale (from 5 = strongly agree to 1 = strongly disagree). Consensus was defined as ≥80% agreement (scores 4 + 5).

Results

All 22 statements achieved consensus (range: 83–100%). Strong agreement (≥90%) was reached for statements regarding the pathophysiological rationale (infection-inflammation-oxidative stress cycle), resveratrol’s pleiotropic mechanisms of action, the role of CMBG in enhancing stability and bioavailability, and clinical efficacy in respiratory infections and allergic rhinitis. The mean scores ranged from 4.2 to 4.9, indicating high expert agreement across all domains.

Conclusions

This multidisciplinary Delphi Consensus provides evidence-based recommendations for the use of intranasal CMBG-resveratrol to manage upper airway diseases, particularly respiratory infections and allergic rhinitis. The formulation’s multitarget approach addresses the complex pathophysiology of these conditions through simultaneous antimicrobial (mainly antiviral), anti-inflammatory, and immunomodulatory effects.

Schlagwörter

Stichwörter der Autor:innen

Delphi consensusallergic rhinitiscarboxymethyl-β-glucanrespiratory infectionsresveratrolupper airway diseases

Autor:innen und Institutionen

  • Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy.
  • Board of Physicians of Brescia, 25035 Brescia, Italy.
  • Faculty of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.
  • Department of Public Health and Infectious Diseases, University of Rome "Sapienza", 00185 Rome, Italy.
  • Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.
  • Pediatric Pulmonology and Respiratory Endoscopy Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, 16147 Genova, Italy.

ORCID-Profile: Giorgio Ciprandi, Ignazio La Mantia, Michele Miraglia Del Giudice, Matteo Gelardi

Zitieren

APA

Ciprandi, G., Bettoncelli, G., La Mantia, I., Mastromarino, P., Miraglia Del Giudice, M., Rossi, G. A., Rossi, O., Gelardi, M., & Varricchio, A. (2026). Multidisciplinary Delphi Consensus on the Clinical Use of Intranasal Carboxymethyl-β-Glucan-Resveratrol: Evidence-Based Recommendations for Upper Airway Diseases. Journal of Clinical Medicine, 15(8), 3087. https://doi.org/10.3390/jcm15083087

Vancouver

Ciprandi G, Bettoncelli G, La Mantia I, Mastromarino P, Miraglia Del Giudice M, Rossi GA, et al. Multidisciplinary Delphi Consensus on the Clinical Use of Intranasal Carboxymethyl-β-Glucan-Resveratrol: Evidence-Based Recommendations for Upper Airway Diseases. Journal of Clinical Medicine. 2026;15(8):3087. doi:10.3390/jcm15083087

BibTeX
@article{Ciprandi2026,
  author = {Ciprandi, Giorgio and Bettoncelli, Germano and La Mantia, Ignazio and Mastromarino, Paola and Miraglia Del Giudice, Michele and Rossi, Giovanni Arturo and Rossi, Oliviero and Gelardi, Matteo and Varricchio, Attilio},
  title = {Multidisciplinary Delphi Consensus on the Clinical Use of Intranasal Carboxymethyl-β-Glucan-Resveratrol: Evidence-Based Recommendations for Upper Airway Diseases},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {3087},
  doi = {10.3390/jcm15083087}
}
Kostenlos starten →